Trial Profile
A Pilot Study to Explore Basal Insulin Dosing Requirements in Patients With Type 2 Diabetes Treated With Insulin Pump Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2011 Planned end date changed from Jun 2009 to Dec 2011 as reported by ClinicalTrials.gov.